Showing all 12 results

Show sidebar
Show 9 12 18 24
Compare

Idacio (adalimumab-aacf)

£807.87 – £3,533.17
Idacio (adalimumab-aacf) is a prescription medicine indicated for the treatment of multiple conditions, including rheumatoid arthritis, psoriatic arthritis, Crohn’s disease, ulcerative colitis, juvenile idiopathic arthritis, ankylosing spondylitis, and plaque psoriasis1. Idacio is approved by the FDA in the USA, as well as by the EMA in the EU2,3.
Add to wishlist
Select options
Quick view
Compare

Jyseleca (filgotinib)

£1,741.89
Jyseleca (filgotinib) is a medication used in adults to treat moderate to severe rheumatoid arthritis.
Add to wishlist
Select options
Quick view
Compare

Olumiant (baricitinib)

£1,306.70 – £4,455.46
Olumiant (baricitinib) is a medication used for the treatment of rheumatoid arthritis and for the treatment of moderate to severe atopic dermatitis. On November 19, 2020 the U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for Olumiant (baricitinib), in combination with Veklury (remdesivir), to treat COVID-19 patients.
Add to wishlist
Select options
Quick view
Compare

Rinvoq (upadacitinib)

£1,559.25
Rinvoq (upadacitinib) is a medication used to treat adults with active rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis and ankylosing spondylitis.
Add to wishlist
Select options
Quick view
Compare

Skyrizi (risankizumab)

,
£450.00
Skyrizi (risankizumab) is a medication used to treat adults with Plaque Psoriasis and Psoriatic Arthritis.
Add to wishlist
Add to cart
Quick view
Compare

Stelara (ustekinumab)

,
£7,079.70
Stelara (ustekinumab) is a medication used for the treatment of plaque psoriasis, psoriatic arthritis, Crohn's disease, or ulcerative colitis.
Add to wishlist
Select options
Quick view
Compare

Taltz (ixekizumab)

£3,185.16 – £5,033.81
Taltz (ixekizumab) is a medication used for the treatment of moderate to severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Select options
Quick view
Compare

Tremfya (guselkumab)

,
£1,900.00
Tremfya (guselkumab) is a medication used for the treatment of adult patients with moderate-to-severe plaque psoriasis and active psoriatic arthritis.
Add to wishlist
Select options
Quick view
Compare

Truxima (rituximab)

£1,085.70 – £2,325.28
Truxima (rituximab) is a medication used for the treatment of follicular lymphoma and diffuse large B-cell Non-Hodgkin’s Lymphoma (NHL); chronic lymphocytic leukemia (CLL); severe active rheumatoid arthritis and granulomatosis with polyangiitis and microscopic polyangiitis.
Add to wishlist
Select options
Quick view
Compare

Tymlos (abaloparatide)

£3,220.00
Tymlos (abaloparatide) is a medication used for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
Add to wishlist
Select options
Quick view
Compare

Xeljanz (tofacitinib)

£1,198.35
Xeljanz (tofacitinib) is a medication used for the treatment of severely active rheumatoid arthritis or active psoriatic arthritis, in patients who have had an inadequate response or intolerance to methotrexate. It is also used for moderately to severely active ulcerative colitis.
Add to wishlist
Select options
Quick view
Compare

Yuflyma (adalimumab-aaty)

£1,359.49 – £3,533.18
Yuflyma (adalimumab-aaty) is a prescription medicine for the treatment of multiple conditions, including plaque psoriasis, psoriatic and rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, enthesitis-related arthritis, axial spondyloarthritis, Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and non-infectious uveitis
Add to wishlist
Select options
Quick view